Absci (ABSI) Non Operating Income (2020 - 2026)
Absci's Non Operating Income came in at $988,000 for Q2 2026, up 3.5% from $955,000 a year earlier but down 21.9% from the prior quarter.
Powered by 
Analysis
Absci (ABSI) Non Operating Income (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Absci reported Non Operating Income of $5.12 million, up 9.4% year-over-year; for FY2025, it was $5.2 million, down 11.1% from FY2024.
- Going back by year, Non Operating Income was $5.85 million in FY2024 (+15.9%), $5.05 million in FY2023 (+264.5%), $1.39 million in FY2022 and -$34.62 million in FY2021.
- The five-year range for quarterly Non Operating Income is -$4.2 million (Q3 2021) to $1.97 million (Q2 2024).
- Year-over-year, Non Operating Income increased in four of the last eight quarters, with an average decline of 2.9%.
- The fastest year-over-year change in Non Operating Income over five years came in Q3 2023 (growth of 239.1%), and the weakest in Q2 2025 (a decline of 51.5%).
- Business Quant data shows ABSI's Non Operating Income at $1.27 million (Q1 2026), $1.32 million (Q4 2025) and $1.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Absci | 1.63 Bn | 1.01 Bn | - | 988,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 988,000.00 |
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 955,000.00 |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 812,000.00 |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.14 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 396,000.00 |
| Jun 30, 2022 | -63,000.00 |
| Mar 31, 2022 | -70,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Sep 30, 2021 | -4.20 Mn |
API Access
Absci Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ABSI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ABSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ABSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();